Inventiva Pharma

Daix, France

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

$120.0M raised

Jun 2026

Post-IPO Equity

Biopharma Biotechnology Clinical Trials Medical Medical Device

Top Investors

European Investment Bank BlackRock AbbVie Samsara BioCapital Sofinnova Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Inventiva Pharma

How much funding has Inventiva Pharma raised?

Inventiva Pharma has raised $120.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are Inventiva Pharma's investors?

Inventiva Pharma's investors include European Investment Bank, BlackRock, AbbVie, Samsara BioCapital, Sofinnova Partners.

Where is Inventiva Pharma headquartered?

Inventiva Pharma is headquartered in Daix, France.

What does Inventiva Pharma do?

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

What stage is Inventiva Pharma at?

Inventiva Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 2, 2026.

MLA

"Inventiva Pharma — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/inventiva-pharma. Accessed July 1, 2026.

APA

VCBacked. (2026). Inventiva Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/inventiva-pharma

Wikipedia (cite web)

{{cite web |title=Inventiva Pharma — Funding & Investors |url=https://www.vcbacked.co/company/inventiva-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 2, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.